Why do some patients with autoimmune disease respond to treatment while others may not? Understanding these insights can offer scientists potential clues about the underlying cause of disease. This episode, sponsored by AbbVie, explores the approaches scientists use to help drive progress in immunology research like reverse translation – a process that works from “bedside to bench” using clinical observation and patient data to inform and refine drug development earlier on in the process. Not intended for UK audiences.

To learn more about AbbVie’s efforts in immunology, visit: https://www.abbvie.com/science/areas-of-focus/immunology.html